CNS · trading date Oct 12, 2026 · previous close $69.19 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
—
Net income
$153.22M
Total assets
$876.69M
Total liabilities
$242.85M
Stockholders' equity
$561.95M
Cash & equivalents
$145.45M
Operating income
$177.74M
Operating cash flow
-$120.44M
Capital expenditures
$5.98M
Fiscal year 2025, via 10-K filed 2026-02-27.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$126.42M
Free cash flow margin
—
Liabilities / assets
27.7%
Equity / assets
64.1%
CapEx / revenue
—
Operating cash flow / net income
-0.79×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
New York, NY 10036
1166 AVENUE OF THE AMERICAS
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:43 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.